ATE415964T1 - Abführzusammensetzung,welche l-arginine enthält - Google Patents
Abführzusammensetzung,welche l-arginine enthältInfo
- Publication number
- ATE415964T1 ATE415964T1 AT00968147T AT00968147T ATE415964T1 AT E415964 T1 ATE415964 T1 AT E415964T1 AT 00968147 T AT00968147 T AT 00968147T AT 00968147 T AT00968147 T AT 00968147T AT E415964 T1 ATE415964 T1 AT E415964T1
- Authority
- AT
- Austria
- Prior art keywords
- arginine
- composition containing
- gastrointestinal tract
- release formulation
- laxative
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title abstract 2
- 239000008141 laxative Substances 0.000 title abstract 2
- 230000002475 laxative effect Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 210000000664 rectum Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924636.5A GB9924636D0 (en) | 1999-10-18 | 1999-10-18 | Laxative preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE415964T1 true ATE415964T1 (de) | 2008-12-15 |
Family
ID=10862937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00968147T ATE415964T1 (de) | 1999-10-18 | 2000-10-18 | Abführzusammensetzung,welche l-arginine enthält |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050080137A1 (de) |
| EP (2) | EP1251844B1 (de) |
| JP (1) | JP2003512320A (de) |
| AT (1) | ATE415964T1 (de) |
| AU (1) | AU7809900A (de) |
| DE (1) | DE60041004D1 (de) |
| GB (1) | GB9924636D0 (de) |
| WO (1) | WO2001028538A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002020005A1 (en) * | 2000-09-06 | 2002-03-14 | Norgine Europe B.V. | Use of arginine in endoscopy and other medical procedures |
| US20040071779A1 (en) * | 2002-10-09 | 2004-04-15 | Keiser Dale Arthur | Gelled laxative compositions |
| WO2009022358A1 (en) * | 2007-08-10 | 2009-02-19 | Luigi Ambrosio | Superabsorbent polymer hydro gels and a method of preparing thereof |
| EP2263666A4 (de) * | 2008-03-11 | 2011-11-09 | Ajinomoto Kk | Mittel und nahrungsmittel zur prävention/linderung von funktionalen magen-darm-erkrankungen |
| EP2438077B1 (de) * | 2009-06-03 | 2013-12-04 | Aptalis Pharma U.S. Inc. | L-zucker als kolonreinigungsmittel und anwendungen davon |
| CN113041213B (zh) * | 2021-03-22 | 2022-11-01 | 华熙生物科技股份有限公司 | 一种含透明质酸和四氢嘧啶的直肠栓剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1272149B (it) * | 1993-03-26 | 1997-06-11 | Zambon Spa | Composizione farmeceutiche ad attivita' analgesica |
| US6297212B1 (en) * | 1994-05-31 | 2001-10-02 | Gregory M. Fahy | Growth hormone therapy and related methods and pharmaceutical compositions |
| US5595753A (en) * | 1995-04-14 | 1997-01-21 | President And Fellows Of Harvard College | Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract |
| US5827889A (en) * | 1996-04-23 | 1998-10-27 | Robert Cunico | Anal fissure treatment preparation and method |
| DE69705106T2 (de) * | 1996-11-13 | 2001-09-20 | C.B. Fleet Co., Inc. | Darmreiniger auf Basis von umhülltem Natriumphosphat |
| GB9706318D0 (en) | 1997-03-26 | 1997-05-14 | Bryant Andrew E | Therapeutic formulations |
| US6391869B1 (en) * | 1998-12-14 | 2002-05-21 | Cellergy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
| US6395736B1 (en) * | 1998-12-14 | 2002-05-28 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
| US6548545B1 (en) * | 2001-10-01 | 2003-04-15 | 40 J's Llc | Treatment of interstitial cystitis using topical application of menthol and L-arginine |
-
1999
- 1999-10-18 GB GBGB9924636.5A patent/GB9924636D0/en not_active Ceased
-
2000
- 2000-10-18 EP EP00968147A patent/EP1251844B1/de not_active Expired - Lifetime
- 2000-10-18 EP EP08020742A patent/EP2022494A3/de not_active Withdrawn
- 2000-10-18 JP JP2001531368A patent/JP2003512320A/ja active Pending
- 2000-10-18 WO PCT/GB2000/004017 patent/WO2001028538A2/en not_active Ceased
- 2000-10-18 DE DE60041004T patent/DE60041004D1/de not_active Expired - Lifetime
- 2000-10-18 AU AU78099/00A patent/AU7809900A/en not_active Abandoned
- 2000-10-18 AT AT00968147T patent/ATE415964T1/de not_active IP Right Cessation
-
2002
- 2002-04-12 US US10/110,714 patent/US20050080137A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050080137A1 (en) | 2005-04-14 |
| EP2022494A2 (de) | 2009-02-11 |
| WO2001028538A3 (en) | 2002-06-13 |
| EP2022494A3 (de) | 2009-05-27 |
| EP1251844B1 (de) | 2008-12-03 |
| WO2001028538A2 (en) | 2001-04-26 |
| AU7809900A (en) | 2001-04-30 |
| EP1251844A2 (de) | 2002-10-30 |
| DE60041004D1 (de) | 2009-01-15 |
| GB9924636D0 (en) | 1999-12-22 |
| JP2003512320A (ja) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE235895T1 (de) | Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis | |
| KR100838686B1 (ko) | 방출 ｐＨ 범위 및/또는 속도 제어 조성물 | |
| FR2808685B1 (fr) | Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires | |
| DK1206261T3 (da) | Farmaceutiske præparater, der omfatter clavuansyre eller derivater deraf, til behandlingen af adfærdsmæssige sygdomme | |
| JP2005515966A5 (de) | ||
| DK0893998T4 (da) | Afgivelse af nikotin i tyktarmen med henblik på behandling af inflammatoriske tarmsygdomme | |
| BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
| MA26859A1 (fr) | Forme posologique de medicament commandée par un hydrogel. | |
| WO2001085137A3 (en) | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use | |
| CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
| BR9914360A (pt) | N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5 | |
| SE9704833D0 (sv) | New formulation | |
| EP0966966A3 (de) | Nefazodon enthaltende Dosierungsform | |
| ATE247953T1 (de) | Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| ATE375789T1 (de) | Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel | |
| Hammoodi et al. | Mutual prodrugs for colon targeting: A review | |
| CY1105849T1 (el) | Χρηση αντισηπτικων στην εμπορικη κατασκευη φαρμακευτικου παρασκευασματος προς αποτροπη ή θepαπεια εναντι φλεγμονων εντος του ανθρωπινου σωματος | |
| CA2389032A1 (en) | Preventive or therapeutic agents for inflammatory diseases of intestine | |
| DK1401405T3 (da) | Orale, farmaceutiske sammensætninger med forbedret biotilgængelighed | |
| ATE415964T1 (de) | Abführzusammensetzung,welche l-arginine enthält | |
| WO2005065648A3 (en) | Novel drug compositions and dosage forms of topiramate | |
| AU2173101A (en) | Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents | |
| NO20024108D0 (no) | Oralt administrert kontrollert leveringssystem for þn daglig administrering av ciprofloxacin | |
| ATE253369T1 (de) | Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |